Both the ingrowth of surrounding bone tissue and the promotion of the development of low differentiated progenitor cells in bone cells are to be supported by a bone substitute material. The chemical, physical, and mechanical properties are important characteristics of a bone substitute material and define its suitability for clinical application.
The scientific evidence shows that allografts are the second best option to patient's own bone compared to other bone substitutes.1 MinerOss™ A is a processed allogenic bone tissue that offers proven, reliable, and predictable surgical outcomes comparable to autologous bone harvested from intra-oral donor sites.
MinerOss™ A is an allograft predominantly derived from human donor femoral heads post hip replacement surgery. The donor tissue is thoroughly inspected and undergoes a strict serological screening protocol.
Thanks to its natural bone composition consisting of mineralised human collagen, MinerOss™ A shows a high biologic regeneration capability in combination with natural remodelling. Therefore, MinerOss™ A is an excellent alternative to autologous bone, meaning that there is no need for an intraoral surgical donor site, which reduces morbidity for the patient.
MinerOss™ A undergoes high safety standards in its production process and guarantees a 5-year shelf life at 5°C - 30°C.
Optimal for the following indications
Large bone defects where one bone wall is maintained can be restored to replace missing or inadequate bone tissue, or for filling or stabilizing bone defects by using MinerOss™ A in combination with a collagen membrane.